Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Three strategies for managing loss of exclusivity successfully
Pharmaforum
Thu, 08/29/19 - 11:49 pm
Tags:
market exclusivity, patents, Humalog, Viagra, Eli Lilly, Pfizer
Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.
BioSpace
Thu, 08/29/19 - 08:16 pm
Tags:
diabetes, insulin, Humalog, generics, Eli Lilly, Lispro
Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis
Endpoints
Mon, 08/26/19 - 09:33 am
Tags:
Eli Lilly, monoclonal antibodies, Taltz, ankylosing spondylitis, FDA
Olumiant from Lilly, Incyte clears third eczema study, but who will use it?
Endpoints
Mon, 08/26/19 - 09:28 am
Tags:
Eli Lilly, olumiant
Eli Lilly Wins Arbitration Hearing Against Adocia
BioSpace
Sun, 08/25/19 - 05:00 pm
Tags:
Eli Lilly, intellectual property, Adocia
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe
Pharmaforum
Wed, 08/21/19 - 10:37 am
Tags:
Eli Lilly, biosimilars, osteoporosis, Forsteo, Europe, Stada, Gedeon Richter
Lilly’s first crowdsourced digital health contest seeks solutions for IBD
Fierce Pharma
Tue, 08/20/19 - 10:59 pm
Tags:
IBD, Eli Lilly, innovation challenges, innovation, digital health
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Reuters
Sat, 08/17/19 - 12:08 am
Tags:
Roche, Rozlytrek, Bayer, Eli Lilly, personalized medicine
Eli Lilly's Taltz bests J&J rival Tremfya in head-to-head psoriasis tilt
Fierce Pharma
Tue, 08/13/19 - 11:40 am
Tags:
Eli Lilly, Taltz, JNJ, Tremfya, psoriasis
Most insurers don't cover Eli Lilly's half-priced insulin
Beckers Hospital Review
Mon, 08/12/19 - 05:30 pm
Tags:
insulin, diabetes, drug pricing, Eli Lilly, PBMs, insurers
Apple, Eli Lilly research whether devices can detect dementia signs
Medtech Dive
Fri, 08/9/19 - 10:40 am
Tags:
Apple, Eli Lilly, dementia, wearables, devices, Evidation, Apple Watch, iPhone
Lilly shuffles executives overseeing oncology and M&A
Biopharma Dive
Thu, 08/8/19 - 11:28 pm
Tags:
Eli Lilly, oncology, M&A
Eli Lilly confirms probe by New York’s Attorney General over insulin prices
CNBC
Mon, 08/5/19 - 10:34 pm
Tags:
Eli Lilly, drug pricing, insulin, diabetes, New York
Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study
Endpoints
Mon, 08/5/19 - 10:59 am
Tags:
Eli Lilly, Emgality, clinical trials, migraines, chronic migraine, episodic migraine
3 Lung Cancer Stocks That Could Soar in September
Motley Fool
Mon, 08/5/19 - 12:04 am
Tags:
lung cancer, Eli Lilly, Amgen, AstraZeneca
New York investigating 3 insulin makers' pricing strategies
Beckers Hospital Review
Tue, 07/30/19 - 11:09 pm
Tags:
New York, insulin, diabetes, Sanofi, Eli Lilly, Novo Nordisk
Lilly's Emgality powers ahead with 'best-in-class' CGRP access
Fierce Pharma
Tue, 07/30/19 - 04:21 pm
Tags:
Eli Lilly, Emgality, migraines, Amgen, Aimovig, Teva Pharmaceutical, Ajovy
Lilly cancer push boosted by survival benefit to key drug
Biopharma Dive
Tue, 07/30/19 - 11:31 am
Tags:
Eli Lilly, Verzenio, metastatic breast cancer, clinical trials
Lilly drops PD-L1/TIM-3 bispecific from clinical pipeline
Fierce Biotech
Tue, 07/30/19 - 11:23 am
Tags:
Eli Lilly, bispecific antibodies, solid tumors
After painting a poor safety profile, Pfizer and Eli Lilly are shooting for a new pain drug OK anyway
Endpoints
Mon, 07/29/19 - 09:30 am
Tags:
Pfizer, Eli Lilly, FDA, tanezumab, anti-TNF

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.